DiscoverClinical Research CoachRob Freishtat- Revolutionizing Clinical Trials in Rare Disease: Efficiency and Patient-Centric Solutions
Rob Freishtat- Revolutionizing Clinical Trials in Rare Disease: Efficiency and Patient-Centric Solutions

Rob Freishtat- Revolutionizing Clinical Trials in Rare Disease: Efficiency and Patient-Centric Solutions

Update: 2025-01-21
Share

Description

In this episode, I chat with Rob Freishtat, Co-Founder and President of Uncommon Cures and former emergency physician. Rob shares his journey into the world of rare disease clinical research and his mission to transform the clinical trial landscape.




We discuss the unique challenges of diagnosing and treating rare diseases and the critical role of clinical trials in advancing treatments.




Rob shares howUncommon Cures, works to remove the unnecessary "barnacles" that have accumulated over decades to reduce delays and inefficiencies.




With home-based visits, after hours appointments and family involvement, Rob outlines his approaches to reduce friction and improve the patient experience make clinical trials more accessible.




We also explore the impact of AI in rare disease, strategies to enhance patient recruitment, and the importance of advocating for better regulatory pathways.




Whether you're a patient, a healthcare professional, or simply curious about rare disease advancements, this episode offers valuable insights into the future of clinical research.




Dr. Robert J. Freishtat is a highly regarded physician-executive renowned for his transformative impact on biotechnology ventures, clinical medicine, and international healthcare initiatives. With a storied professional history spanning over two decades, Dr. Freishtat has consistently demonstrated his ability to lead high-stakes organizational transformations, drive clinical solutions to the marketplace, and forge strategic global partnerships.


As the President and Co-Founder of Uncommon Cures, Dr. Freishtat has transformed clinical trials for rare diseases by implementing a unique trial model that eliminated inefficiencies and accelerated drug approval processes. Under his leadership, the company has expanded rapidly and secured key contracts to establish strategic partnerships with leading pharmaceutical companies. Previously, Dr. Freishtat served as the Co-Founder and Chief Scientific Officer of Adipomics, where he commercialized groundbreaking obesity-related diagnostics and empowered innovation – securing critical funding for entrepreneurial milestones.




You can connect with Dr Freishtat at: https://uncommoncures.com/contact-us/


Or on Linked In: https://www.linkedin.com/in/rob-freishtat/



Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Rob Freishtat- Revolutionizing Clinical Trials in Rare Disease: Efficiency and Patient-Centric Solutions

Rob Freishtat- Revolutionizing Clinical Trials in Rare Disease: Efficiency and Patient-Centric Solutions

Leanne Woehlke